Print Page | Contact Us | Sign In | Join ACAM
News & Press: ACAM Action Alerts

Methylene blue–a new/old drug for treating Lyme disease

Wednesday, March 27, 2024  

From lymedisease.org, written by Dr. Erica Lehman:
Methylene blue - a new/old drug for treating Lyme disease
https://www.lymedisease.org/methylene-blue-lyme-disease/

Methylene blue (MB) is truly a fascinating compound and one of the most revolutionary medications to hit the functional medicine and tick-borne disease spheres.

It was first synthesized by a German chemist Heinrich Caro in 1876. Initially, it was known as methylthioninium chloride and later named methylene blue due to its distinctive color.

Its early applications include use as a dye and staining agent for biological tissue. It was used in histology and microscopy to enhance the visibility of cell structures because it can stain DNA. I used it early on in my ophthalmic surgery training to mark the sclera (the white part of the eye), for cataract and retinal detachment surgery.
READ MORE


Connect With Us

380 Ice Center Lane, Suite C

Bozeman, MT 59718

Our mission

The American College for Advancement in Medicine (ACAM) is a not-for-profit organization dedicated to educating physicians and other health care professionals on the safe and effective application of integrative medicine.